Errors in this step cascade through your entire protocol, making accurate dosing impossible regardless of how carefully you plan timing and amount
In this guide, well break down: What AOD9604 actually is and how it works The mechanism of action versus advertised fatloss claims Clinical evidence on weight reduction and body composition Whether it stacks well with other peptides like CJC1295, Ipamorelin, or Tesamorelin Potential side effects and safety concerns How to separate evidencebased strategies from marketing myths What Is AOD9604
This duration allows sufficient time to produce meaningful fat loss results while avoiding the plateau effect that can occur with extended continuous use
AOD-9604, a synthetic fragment derived from the C-terminal region of human growth hormone, has been subjected to extensive clinical evaluation involving over 900 participants across six randomized controlled trials
This classification allows for their use only for research development and laboratory studies
The Phase 2 clinical trial showed roughly 2-3 kg more fat loss than placebo over 12 weeks, with no impact on blood sugar, insulin, IGF-1, or any hormonal marker